Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01805141 · ClinicalTrials.gov registry record
Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 24
- Enrollment target
NCT01805141: Completed study, sponsored by Stanford University.
NCT01805141 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 24 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01805141 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The investigators hope to learn whether perfusion CT is a useful way to assess primary cervical tumor microenvironment and whether there is a relationship between pretreatment perfusion CT measurements and primary cervical tumor size, lymph node involvement (as assessed by standard of care pretreatment fludeoxyglucose Positron emission tomography/CT (FDG-PET/CT)), and treatment response (as assessed by standard of care 3-month post-therapy FDG-PET/CT).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2013-08 |
| Est. Completion | 2018-10-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01805141
The ClinicalTrials.gov registry entry for NCT01805141 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01805141 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01805141 about?
NCT01805141 is a clinical study titled "Phase I Pilot Study to Evaluate the Prognostic Value of Perfusion CT for Primary Cervical Cancer". The investigators hope to learn whether perfusion CT is a useful way to assess primary cervical tumor microenvironment and whether there is a relationship between pretreatment perfusion CT measurements and primary cervical tumor size, lymph node involvement (as assessed by standard of care pretreatm...
What is the current status of trial NCT01805141?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2013-08. Estimated completion is 2018-10-04.
Who is sponsoring clinical trial NCT01805141?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.